Skip to main navigation
Quantum Si logo
  • Technology
  • Products
  • Applications
    • Antibody Characterization
    • Biomarker Identification
    • Protein Identification
    • Protein Variant
    • PTM Analysis
  • Resources
  • Investors
    • Press Releases
    • Events and Presentations
    • Stock Information
    • Financials
    • Governance
    • Investor Resources
  • About Us
    • Careers
    • Leadership
  • Contact Us
Select Page
Quantum-Si Incorporated logo
    • Technology
    • Products
    • Applications
      • Antibody Characterization
      • Biomarker Identification
      • Protein Identification
      • Protein Variant
      • PTM Analysis
    • Resources
    • Investors
      • Press Releases
      • Events and Presentations
      • Stock Information
      • Financials
      • Governance
      • Investor Resources
    • About Us
      • Careers
      • Leadership
    • Contact Us

News Details

  • Overview
  • Press Releases
  • Events & Presentations
    Events Presentations
  • Stock Information
    Stock Quote & Chart Analyst Coverage Historic Price Lookup
  • Financials
    Quarterly Results Annual Reports SEC Filings
  • Governance
    Governance Highlights Leadership Board of Directors Committee Composition
  • Investor Resources
    Investor FAQs Investor Email Alerts Investor Contact

Quantum-Si to Report First Quarter 2024 Financial Results on May 9, 2024

April 18, 2024
PDF Version

BRANFORD, Conn.--(BUSINESS WIRE)--Apr. 18, 2024-- Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced that it will report financial results for the first quarter 2024 on Thursday, May 9, 2024. Company management will host a conference call to discuss financial results and provide a business update on the same day at 4:30 PM ET.

Individuals interested in listening to the conference call may do so by joining the live webcast on the Investors section of the Quantum-Si website under Events and Presentations.

Alternatively, individuals can register here to receive a dial-in number and personalized PIN to participate in the call. An archived webcast of the event will be available for replay following the event.

About Quantum-Si Incorporated

Quantum-Si, The Protein Sequencing Company™, is focused on revolutionizing the growing field of proteomics. The Company's suite of technologies is powered by a first-of-its-kind semiconductor chip designed to enable next-generation single-molecule protein sequencing and digitize proteomic research in order to advance drug discovery and diagnostics beyond what has been possible with DNA sequencing. Learn more at quantum-si.com or follow us on LinkedIn or X.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240418068472/en/

Investor Contact
Jeff Keyes, Chief Financial Officer
ir@quantum-si.com

Media Contact
Katherine Atkinson, SVP of Commercial Marketing
media@quantum-si.com

Source: Quantum-Si Incorporated

  • Print Page
  • Email Alerts
  • RSS Feeds
  • Contact IR
Quantum-Si Incorporated logo
© Copyright 2026 QuantumSi | All rights reserved.
Follow us
  • LinkedIn
  • Twitter
  • Youtube
  • Instagram
  • Facebook